Varlilumab (anti-CD27), CAS [[1393344-72-3]]

Produktübersicht

• Artikelname: Varlilumab (anti-CD27), CAS [[1393344-72-3]]
• Artikelnummer: MCE-HY-P99057A
• Hersteller Artikelnummer: HY-P99057A
• Alternativnummer: MCE-HY-P99057A-10MG,MCE-HY-P99057A-1MG,MCE-HY-P99057A-5MG
• Hersteller: MedchemExpress
• Kategorie: Antikörper
• Alternative Synonym: CDX-1127 (anti-CD27)

Produktbeschreibung

Varlilumab (CDX-1127) (anti-CD27) is an agonist anti-CD27 monoclonal antibody. Varlilumab (anti-CD27) can promote T cell expansion and activate the immune response. Varlilumab (anti-CD27) has anti-tumor activity and can be used in the research of hematological malignancies and solid tumors[1][2].

Produkteigenschaften

• Molekulargewicht: (145.58 kDa)
• Reinheit: 99.68
• CAS Nummer: [1393344-72-3]
• Target-Kategorie: TNF Receptor,Transmembrane Glycoprotein

Anwendungsbeschreibung

• Anwendungsbeschreibung: MCE Product type: Inhibitory Antibodies